Article Text

PDF

209 TRANSCRIPTOME ANALYSIS IDENTIFIES A NOVEL MECHANISM OF CAMP-MEDIATED GROWTH ARREST IN VSMC: PKA AND EPAC SYNERGISE TO SUPPRESS EGR1 EXPRESSION
  1. T Kimura,
  2. C Hindmarch,
  3. A Newby,
  4. M Bond
  1. University of Bristol

    Abstract

    Cyclic AMP signalling promotes VSMC quiescence in healthy vessels and during vascular healing following injury. We recently demonstrated that cAMP-sensitive PKA and Epac signalling pathways synergise to inhibit VSMC proliferation but the underlying mechanisms are not understood.

    Using PKA and Epac-selective agonists and microarray analysis we tested the hypothesis that PKA and Epac block VSMC proliferation via coordinate regulation of immediate early genes required for cell-cycle progression. Epac agonist significantly enhanced PKA-dependent inhibition of EGR1 mRNA (4.6±0.38 fold for PKA vs 13.8±1.09 fold for PKA+EPAC, p<0.05) and protein expression (1.9±0.18 fold for PKA vs 7.1±0.8 fold for PKA+EPAC, p<0.05). This inhibition was replicated by elevating endogenous cAMP with forskolin (4.8±1.9 fold, p<0.05), adenosine (3.4±0.7, p<0.05), A2B receptor agonist BAY60-6583 (4±1.2 fold, p<0.05) or Cicaprost (3.7±0.5 fold, p<0.05). Importantly, dominant-negative EGR1 inhibited VSMC proliferation.

    cAMP-dependent inhibition (3.9±0.8 fold, p<0.05) of EGR1 transcription (reporter gene activity) was associated with a potent stimulation of CREB activity (225±72 fold, p<0.05). However, expression of dominant-negative CREB did not prevent cAMP-dependent inhibition of EGR1 expression. cAMP-mediated EGR1 repression was also associated with MAPK inhibition. However, inhibition of EGR1 transcription preceded MAPK inhibition. cAMP retains the ability to inhibit EGR1 expression in MAPK-blocked cells, demonstrating MAPK and CREB independent inhibition of Egr1 expression by cAMP. Inhibition of EGR1 transcription was associated with a significant (to 21.4±6.4%, p<0.05) inhibition of SRF activity, suggesting a role for SRF inhibition in cAMP-mediated EGR1 repression and inhibition of proliferation.

    In summary, our results demonstrate that PKA and Epac synergise to inhibit VSMC proliferation by rapidly inhibiting EGR1 expression via a mechanism that probably involves inhibition of SRF activity. This also provides a mechanistic explanation for the CREB and MAPK-independent anti-mitogenic effects of cAMP in VSMC.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.